Table 6.

Availability of variables required for adverse drug reporting by the main hospital electronic system

Variables to identify suspect products	EHR/EMR	CPOE	eMAR	BCMA	BCMP	IR
Sample size (n)	57	57	59	38	23	33
Dose	95	95	98	95	91	85
Administration route	96	93	97	89	78	88
Label strength	86	82	86	82	87	79
Brand name	82	81	81	76	74	76
Active ingredient	53	60	54	50	43	55
Concomitant medications	67	63	61	39	35	33
Manufacturer	23	14	15	34	70	30
NDC	28	18	15	37	52	27
Expiry date	19	14	15	29	57	27
Lot number	14	9	10	16	39	27

Data are presented as % unless otherwise indicated

Sample size is 59 respondents employed in a hospital setting

ADE adverse drug event, BCMA Barcode-enabled Medication Administration, BCMP Bar-Code Medication Preparation Technologies, CPOE Computerized Physician Order Entry system, EHR electronic health record, eMAR Electronic Medication Administration Record, EMR electronic medical record, IR electronic incident reporting system, NDC National Drug Code